Reneo Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)66holders +4
20new positions
17sold out
4famous investors
$1.51avg. 13F price*
At the end of Q2 2024, 66 institutions reported holding Reneo Pharmaceuticals Inc. in their 13F filings, up 4 from Q1 2024. 20 opened new positions and 17 sold out. The largest holders were NEA Management Company, LLC ($7.2M), Tang Capital Management LLC ($4.5M) and Highbridge Capital Management LLC ($4.4M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Reneo Pharmaceuticals Inc.
- CUSIP
- 75974E103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $1.7M |
| Exits | 17 | $1.7M |
All 13F filers, Q1 2024 → Q2 2024: 2,335,824 shares bought and 2,425,105 shares sold, net −89,281 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 66 holders
| NEA Management Company, LLC | 0.54% | No change | 4,785,494 | $7.2M |
| Tang Capital Management LLC | 0.46% | Reduce -0.0% | 2,996,260 | $4.5M |
| Highbridge Capital Management LLC | 1.16% | Add +6.5% | 2,915,376 | $4.4M |
| Carlyle Group Inc. | 0.39% | No change | 2,698,957 | $4.2M |
| BML Capital Management, LLC | 2.96% | Add +22.7% | 2,672,194 | $4.0M |
| RiverVest Venture Management LLC | 56.07% | No change | 2,534,220 | $3.8M |
| Octagon Capital Advisors LP | 0.56% | No change | 2,250,000 | $3.4M |
| Aisling Capital Management LP | 0.58% | No change | 886,075 | $1.3M |
| Vanguard Group Inc. | 0.00% | Reduce -9.1% | 882,104 | $1.3M |
| Nantahala Capital Management, LLC | 0.09% | New | 547,804 | $846K |
| Vestal Point Capital, LP | 0.06% | Add +84.5% | 545,000 | $823K |
| Aldebaran Capital, LLC | 0.63% | Add +12.9% | 447,616 | $676K |
| Renaissance Technologies | 0.00% | Reduce -25.5% | 442,200 | $668K |
| Acuitas Investments, LLC | 0.33% | Add +0.5% | 406,209 | $613K |
| BlackRock Inc. | 0.00% | Reduce -70.5% | 293,651 | $443K |
| Geode Capital Management, LLC | 0.00% | Reduce -39.6% | 201,036 | $304K |
| Morgan Stanley | 0.00% | Reduce -12.6% | 198,518 | $300K |
| Opaleye Management Inc. | 0.06% | New | 165,000 | $249K |
| Goldman Sachs Group Inc. | 0.00% | Add +272.4% | 144,307 | $218K |
| Bank of Montreal | 0.00% | Reduce -2.5% | 130,743 | $213K |
| Northern Trust Corp. | 0.00% | Add +5.1% | 117,860 | $178K |
| Two Sigma Investments, LP | 0.00% | Reduce -14.3% | 111,856 | $169K |
| Millennium Management | 0.00% | New | 109,987 | $166K |
| JBF Capital, Inc. | 0.02% | No change | 80,000 | $121K |
| Two Sigma Advisers, LP | 0.00% | Add +362.4% | 74,900 | $113K |
| Marquette Asset Management, LLC | 0.02% | No change | 73,770 | $111K |
| State Street Corp. | 0.00% | Reduce -71.0% | 71,636 | $108K |
| Susquehanna International Group, LLP | 0.00% | Add +549.7% | 69,619 | $105K |
| Jane Street Group, LLC | 0.00% | New | 62,039 | $94K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 55,676 | $84K |
| Verition Fund Management LLC | 0.00% | New | 55,043 | $83K |
| Centiva Capital, LP | 0.00% | New | 24,000 | $36K |
| CSS LLC | 0.01% | No change | 20,288 | $31K |
| Squarepoint Ops LLC | 0.00% | New | 19,487 | $29K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 19,347 | $29K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 18,027 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +57.6% | 14,939 | $23K |
| Qube Research & Technologies Ltd | 0.00% | New | 14,218 | $21K |
| Dimensional Fund Advisors LP | 0.00% | No change | 13,327 | $20K |
| FMR LLC | 0.00% | Add +686.4% | 12,622 | $19K |
| Paloma Partners Management Co | 0.00% | New | 11,675 | $18K |
| UBS Group AG | 0.00% | Reduce -5.8% | 11,192 | $17K |
| Citadel Advisors | 0.00% | Reduce -83.5% | 10,906 | $16K |
| AQR Capital Management | 0.00% | New | 10,400 | $16K |
| Citigroup Inc. | 0.00% | Add +43.6% | 8,669 | $13K |
| JPMorgan Chase & Co. | 0.00% | Reduce -47.3% | 7,922 | $12K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 6,508 | $10K |
| Group One Trading LLC | 0.00% | Reduce -22.4% | 5,893 | $9K |
| Point72 (DIFC) Ltd | 0.00% | New | 5,021 | $8K |
| Russell Investments Group, Ltd. | 0.00% | Add +3764.6% | 4,251 | $6K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -38.5% | 3,927 | $6K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 3,829 | $6K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 3,200 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -77.5% | 1,200 | $2K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 998 | $2K |
| Rhumbline Advisers | 0.00% | Reduce -91.0% | 983 | $1K |
| Bank of America Corp. | 0.00% | Reduce -78.3% | 947 | $1K |
| Macquarie Group Ltd. | 0.00% | New | 647 | $977 |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -10.6% | 353 | $533 |
| Arax Advisory Partners | 0.00% | New | 171 | $259 |
| Farther Finance Advisors, LLC | 0.00% | Add +200.0% | 117 | $181 |
| New York State Common Retirement Fund | 0.00% | Reduce -81.5% | 118 | $178 |
| Barclays PLC | 0.00% | Reduce -99.4% | 46 | $70 |
| Nisa Investment Advisors, LLC | 0.00% | New | 40 | $60 |
| Royal Bank of Canada | 0.00% | Reduce -98.8% | 9 | $0 |
| Cwm, LLC | 0.00% | New | 276 | $0 |
"% of holder's portfolio" is RENEO PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Reneo Pharmaceuticals Inc. the manager owns.